BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 26050197)

  • 1. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
    Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
    Zhao S; Chen SR; Yang XF; Shen DF; Takano Y; Su RJ; Zheng HC
    Oncotarget; 2017 Jan; 8(5):7502-7520. PubMed ID: 27447746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.
    Tu SP; Liston P; Cui JT; Lin MC; Jiang XH; Yang Y; Gu Q; Jiang SH; Lum CT; Kung HF; Korneluk RG; Wong BC
    Int J Cancer; 2009 Aug; 125(3):688-97. PubMed ID: 19358264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
    Gong Y; Ren J; Liu K; Tang LM
    World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.
    Zhao S; Yang XF; Shen DF; Gao Y; Shi S; Wu JC; Liu HX; Sun HZ; Su RJ; Zheng HC
    Oncotarget; 2016 Aug; 7(34):54596-54615. PubMed ID: 27409347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
    Sun HW; Wu C; Tan HY; Wang QS
    Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells.
    Lu H; Yang XF; Tian XQ; Tang SL; Li LQ; Zhao S; Zheng HC
    Oncotarget; 2016 Aug; 7(35):56508-56525. PubMed ID: 27447743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo.
    Wei WY; Yan LH; Wang XT; Li L; Cao WL; Zhang XS; Zhan ZX; Yu H; Xie YB; Xiao Q
    World J Gastroenterol; 2015 Jan; 21(2):491-501. PubMed ID: 25593464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.
    Zheng HC; Liu JJ; Li J; Wu JC; Yang L; Zhao GF; Zhao X; Jiang HM; Huang KQ; Li ZJ
    Oncotarget; 2017 Apr; 8(14):23603-23612. PubMed ID: 28223542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
    Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
    Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer.
    Ooki A; Yamashita K; Yamaguchi K; Mondal A; Nishimiya H; Watanabe M
    Mol Cancer Res; 2013 Nov; 11(11):1362-74. PubMed ID: 23982217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.